Pyruvate kinase deficiency in 29 Turkish patients with two novel intronic variants
- PMID: 38811201
- DOI: 10.1111/bjh.19575
Pyruvate kinase deficiency in 29 Turkish patients with two novel intronic variants
Abstract
Pyruvate kinase (PK) is a key enzyme of anaerobic glycolysis. The genetic heterogeneity of PK deficiency (PKD) is high, and over 400 unique variants have been identified. Twenty-nine patients who had been diagnosed as PKD genetically in seven distinct paediatric haematology departments were evaluated. Fifteen of 23 patients (65.2%) had low PK levels. The PK:hexokinase ratio had 100% sensitivity for PKD diagnosis, superior to PK enzyme assay. Two novel intronic variants (c.695-1G>A and c.694+43C>T) have been described. PKD should be suspected in patients with chronic non-spherocytic haemolytic anaemia, even if enzyme levels are falsely normal. Total PKLR gene sequencing is necessary for the characterization of patients with PKD and for genetic counselling.
Keywords: PKD; PKLR; enzyme; haemolytic anaemia; pyruvate kinase.
© 2024 British Society for Haematology and John Wiley & Sons Ltd.
References
REFERENCES
-
- Aksu T. Hereditary red blood cell enzymopathies. J Pediatr Acad. 2021;2(1):9–13.
-
- Bianchi P, Fermo E, Glader B, Kanno H, Agarwal A, Barcellini W, et al. Addressing the diagnostic gaps in pyruvate kinase deficiency: consensus recommendations on the diagnosis of pyruvate kinase deficiency. Am J Hematol. 2019;94(1):149–161.
-
- Karaca M, Gök V, Alakuş Sarı Ü, Dündar MA, Aydin F, Özcan A, et al. Triosephosphate isomerase deficiency in an infant. J Transl Pract Med. 2022;1(2):65–67.
-
- Valentine WN, Tanaka KR, Miwa S. A specific erythrocyte glycolytic enzyme defect (pyruvate kinase) in three subjects with congenital non‐spherocytic hemolytic anemia. Trans Assoc Am Phys. 1961;74:100–110.
-
- Aydin Köker S, Oymak Y, Bianchi P, Gözmen S, Karapinar TH, Fermo E, et al. A new variant of PKLR gene associated with mild hemolysis may be responsible for the misdiagnosis in pyruvate kinase deficiency. J Pediatr Hematol Oncol. 2019;41(1):e1–e2.
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources